{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001610820","name":"BriaCell Therapeutics Corp.","summary":"BriaCell Therapeutics Corp. is a clinical-stage biotechnology company developing novel immunotherapies for cancer treatment. Its lead candidate, Bria-IMT, is a targeted immunotherapy currently in a pivotal Phase 3 study in metastatic breast cancer combined with retifanlimab (an anti-PD1 antibody). The company also develops Bria-OTS/Bria-OTS+, a personalized off-the-shelf immunotherapy platform, and Bria-PROS+ for prostate cancer, with FDA Fast Track Designation for Bria-IMT.","people":[],"products":[{"name":"Bria-IMT","type":"platform","description":"Targeted immunotherapy in pivotal Phase 3 study for metastatic breast cancer, combined with retifanlimab; holds FDA Fast Track Designation."},{"name":"Bria-OTS (Bria-BRES)","type":"platform","description":"Personalized off-the-shelf immunotherapy in Phase 1/2 study for metastatic breast cancer; first patient showed complete resolution of a lung metastasis."},{"name":"Bria-OTS+","type":"platform","description":"Advanced form of Bria-OTS platform technology for personalized off-the-shelf immunotherapies for multiple cancer types."},{"name":"Bria-PROS+","type":"platform","description":"Immunotherapy candidate for prostate cancer; received positive feedback from FDA Pre-IND meeting in September 2024."}],"partnerships":[{"partner_name":"Incyte","partnership_type":"development","description":"Incyte manufactures retifanlimab (anti-PD1 antibody) used in BriaCell's Phase 1/2 and Phase 3 combination studies with Bria-IMT.","start_date":null}],"affiliations":[],"origin":{"leaf":"153d326d413212c1691e5daaaeb097218ac30505e2802a0346a8198ba4457928","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"c04c40e8d05e84ff19ff86b16a9d52cec2833f7e1bc3540ddec94347d4e3718c","parent":"b59bd01e10ace87fcd065d379c484cfdd256364a4a35969cd0193932ab243522","source":"0001493152-25-018212","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":383,"hourly_limit":500,"remaining":117,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}